Simulations Plus Extends its Distributor Agreement in Japan with Northern Science Consulting for Monolix™

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has extended its distributor agreement in Japan with Northern Science Consulting for Monolix.

Jonathan Chauvin, President of the Lixoft division, said: “We are excited to be partnering with Northern Science Consulting to further serve the needs of the Japanese scientific markets. We already have a large community of users in Japan, from hospitals to domestic companies, and we have been encouraged by the response to our technology. The Japanese market is quite mature. We see this as the most opportune time to have a local presence in Japan to increase awareness of Monolix while also strengthening the relationships we have already formed with Japanese companies and universities. We are pleased with this agreement as Northern Science Consulting is a well-recognized company in Japan and is already successful in distributing Simulations Plus.”

This distribution agreement for MonolixSuite® will complement the existing arrangement between Simulations Plus and Northern Science Consulting, the distributor for the Company’s software products, including GastroPlus® and ADMET Predictor™, thereby expanding the Company’s reach across discovery, pre-clinical and clinical research and development within the Japanese pharmaceutical industry.

Goh Murakami, Chief Executive Officer at Northern Science Consulting Inc., said: “Founded in 2004, Northern Science Consulting in Japan strongly supports biological science research and development through the provision and support of software. There are many customers, mainly in the laboratories of pharmaceutical companies. We look forward to extending the Simulations Plus relationship with the Lixoft division.”